264 related articles for article (PubMed ID: 34247254)
1. Osteoporotic fractures and subsequent fractures: imminent fracture risk from an analysis of German real-world claims data.
Hadji P; Schweikert B; Kloppmann E; Gille P; Joeres L; Toth E; Möckel L; Glüer CC
Arch Gynecol Obstet; 2021 Sep; 304(3):703-712. PubMed ID: 34247254
[TBL] [Abstract][Full Text] [Related]
2. Risk of subsequent fracture after prior fracture among older women.
Balasubramanian A; Zhang J; Chen L; Wenkert D; Daigle SG; Grauer A; Curtis JR
Osteoporos Int; 2019 Jan; 30(1):79-92. PubMed ID: 30456571
[TBL] [Abstract][Full Text] [Related]
3. Risk of imminent fracture following a previous fracture in a Swedish database study.
Banefelt J; Åkesson KE; Spångéus A; Ljunggren O; Karlsson L; Ström O; Ortsäter G; Libanati C; Toth E
Osteoporos Int; 2019 Mar; 30(3):601-609. PubMed ID: 30680431
[TBL] [Abstract][Full Text] [Related]
4. Predictors of near-term fracture in osteoporotic women aged ≥65 years, based on data from the study of osteoporotic fractures.
Weycker D; Edelsberg J; Barron R; Atwood M; Oster G; Crittenden DB; Grauer A
Osteoporos Int; 2017 Sep; 28(9):2565-2571. PubMed ID: 28593447
[TBL] [Abstract][Full Text] [Related]
5. Risk of major osteoporotic fracture after first, second and third fracture in Swedish women aged 50 years and older.
Söreskog E; Ström O; Spångéus A; Åkesson KE; Borgström F; Banefelt J; Toth E; Libanati C; Charokopou M
Bone; 2020 May; 134():115286. PubMed ID: 32070789
[TBL] [Abstract][Full Text] [Related]
6. Effect of benign prostatic hyperplasia on the development of spine, hip, and wrist fractures.
Yang SC; Chiu YC; Liu PH; Hsieh TJ; Kao YH; Tu YK
Osteoporos Int; 2019 May; 30(5):1043-1049. PubMed ID: 30706096
[TBL] [Abstract][Full Text] [Related]
7. Examining the treatment gap and risk of subsequent fractures among females with a fragility fracture in the US Medicare population.
Keshishian A; Boytsov N; Burge R; Krohn K; Lombard L; Zhang X; Xie L; Baser O
Osteoporos Int; 2017 Aug; 28(8):2485-2494. PubMed ID: 28536737
[TBL] [Abstract][Full Text] [Related]
8. Real-world effectiveness of osteoporosis treatments in Germany.
O'Kelly J; Bartsch R; Kossack N; Borchert J; Pignot M; Hadji P
Arch Osteoporos; 2022 Aug; 17(1):119. PubMed ID: 36044096
[TBL] [Abstract][Full Text] [Related]
9. Fragility fractures and imminent fracture risk in Hong Kong: one of the cities with longest life expectancies.
Wong RMY; Ho WT; Wai LS; Li W; Chau WW; Chow KS; Cheung WH
Arch Osteoporos; 2019 Oct; 14(1):104. PubMed ID: 31659457
[TBL] [Abstract][Full Text] [Related]
10. The significance of recent fracture location for imminent risk of hip and vertebral fractures-a nationwide cohort study on older adults in Sweden.
Lorentzon M; Litsne H; Axelsson KF
Osteoporos Int; 2024 Jun; 35(6):1077-1087. PubMed ID: 38521820
[TBL] [Abstract][Full Text] [Related]
11. Real-world evaluation of osteoporotic fractures using the Japan Medical Data Vision database.
Fujiwara S; Buchanan-Hughes A; Ng A; Page J; Adachi K; Li H
Osteoporos Int; 2022 Oct; 33(10):2205-2216. PubMed ID: 35779100
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the 10-year risk of fracture in Italian postmenopausal women using FRAX®: a north Italian multicenter study.
Pedrazzoni M; Girasole G; Giusti A; Barone A; Pioli G; Passeri G; Palummeri E; Bianchi G
J Endocrinol Invest; 2011 Dec; 34(11):e386-91. PubMed ID: 21750394
[TBL] [Abstract][Full Text] [Related]
13. Incidence of subsequent fractures in the UK between 1990 and 2012 among individuals 50 years or older.
van der Velde RY; Wyers CE; Geusens PPMM; van den Bergh JPW; de Vries F; Cooper C; van de Staa TP; Harvey NC
Osteoporos Int; 2018 Nov; 29(11):2469-2475. PubMed ID: 30030587
[TBL] [Abstract][Full Text] [Related]
14. Serial Bone Density Measurement and Incident Fracture Risk Discrimination in Postmenopausal Women.
Crandall CJ; Larson J; Wright NC; Laddu D; Stefanick ML; Kaunitz AM; Watts NB; Wactawski-Wende J; Womack CR; Johnson KC; Carbone LD; Jackson RD; Ensrud KE
JAMA Intern Med; 2020 Sep; 180(9):1232-1240. PubMed ID: 32730575
[TBL] [Abstract][Full Text] [Related]
15. Hip and other fragility fracture incidence in real-world teriparatide-treated patients in the United States.
Burge RT; Disch DP; Gelwicks S; Zhang X; Krege JH
Osteoporos Int; 2017 Mar; 28(3):799-809. PubMed ID: 28028555
[TBL] [Abstract][Full Text] [Related]
16. Hip fracture predicts subsequent hip fracture: a retrospective observational study to support a call to early hip fracture prevention efforts in post-fracture patients.
Schemitsch E; Adachi JD; Brown JP; Tarride JE; Burke N; Oliveira T; Slatkovska L
Osteoporos Int; 2022 Jan; 33(1):113-122. PubMed ID: 34379148
[TBL] [Abstract][Full Text] [Related]
17. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
[TBL] [Abstract][Full Text] [Related]
18. Determinants of imminent fracture risk in postmenopausal women with osteoporosis.
Barron RL; Oster G; Grauer A; Crittenden DB; Weycker D
Osteoporos Int; 2020 Nov; 31(11):2103-2111. PubMed ID: 32613410
[TBL] [Abstract][Full Text] [Related]
19. The imminent risk of a fracture-existing worldwide data: a systematic review and meta-analysis.
Wong RMY; Wong PY; Liu C; Wong HW; Chung YL; Chow SKH; Law SW; Cheung WH
Osteoporos Int; 2022 Dec; 33(12):2453-2466. PubMed ID: 35776148
[TBL] [Abstract][Full Text] [Related]
20. The risk of major and any (non-hip) fragility fracture after hip fracture in the United Kingdom: 2000-2010.
Gibson-Smith D; Klop C; Elders PJ; Welsing PM; van Schoor N; Leufkens HG; Harvey NC; van Staa TP; de Vries F
Osteoporos Int; 2014 Nov; 25(11):2555-63. PubMed ID: 25001987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
